RxDoctor Payments Data

Calin Savu, MD

Interventional Pain Medicine · Jonesboro, ARNPI 1801976956

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,770 of the $2,759 with a category attached, or 64.2%. 13 manufacturers reported payments, led by Boston Scientific at 54.9% of the total. Reporting peaked in 2021 at $1,798 and has fallen 98.5% since, to $28 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in AR, where the typical reported total is $3,706.

$2,759in general payments, 2019–2025

Across 57 payments — averaging $48.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • Nevro Corp.$617
  • Stimwave Technologies Incorporated$107
  • Curonix LLC$98
  • SPR Therapeutics, Inc$74
  • Si-bone, Inc.$73
  • plus $277 from 7 others

What the payments were for

  • Grants$532%
  • Travel & lodging$93634%
  • Food & beverage$1,77064%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,759 in reported general payments places this provider in the 45th percentile of 29 interventional pain medicine providers in Arkansas.

See all interventional pain medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$86,998
Medicare patients
137
Services billed
1,236

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen857$20,881
MovantikNaloxegol Oxalate27$11,000
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen314$7,426
Gabapentin435$5,710
Pregabalin227$4,131
Oxycodone Hcl220$3,675
Morphine Sulfate ErMorphine Sulfate117$2,940
Methadone Hcl127$2,777
Morphine Sulfate121$2,560
Cyclobenzaprine Hcl176$1,542
Acetaminophen-CodeineAcetaminophen With Codeine27$1,108
Nortriptyline Hcl97$924
Duloxetine Hcl88$880
Fentanyl14$646
Tizanidine Hcl65$637

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Jonesboro

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →